Young Hak Kim Selected Research

Young Hak Kim Research Topics

Disease

81	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2004
29	Neoplasms (Cancer) 06/2022 - 11/2008
15	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2006
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2021 - 11/2008
13	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2005
7	Adenocarcinoma of Lung 09/2017 - 11/2004
5	Disease Progression 05/2020 - 09/2011
5	Brain Neoplasms (Brain Tumor) 08/2015 - 04/2010
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018 - 08/2012
3	Infections 01/2021 - 08/2011
3	Pleural Effusion (Pleural Effusions) 11/2019 - 09/2010
3	Adenocarcinoma 01/2017 - 11/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 06/2014 - 11/2008
2	Malignant Mesothelioma 11/2019 - 07/2012
2	Pneumonia (Pneumonitis) 01/2018 - 07/2012
2	Carcinogenesis 09/2017 - 11/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2017 - 02/2013
2	Thymoma (Thymic Carcinoma) 05/2016 - 05/2006
2	Pain (Aches) 12/2013 - 03/2013
2	Diarrhea 07/2013 - 10/2011
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2011 - 05/2010
2	Breast Neoplasms (Breast Cancer) 07/2009 - 04/2009
1	Radiation Pneumonitis 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Nontuberculous Mycobacterium Infections 01/2021
1	Eosinophilia 11/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Diabetes Mellitus 01/2019
1	Meningeal Carcinomatosis 11/2018
1	Hepatitis 08/2017

Drug/Important Bio-Agent (IBA)

23	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2008
13	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2013 - 04/2010
12	NivolumabIBA 01/2021 - 01/2017
12	Tyrosine Kinase InhibitorsIBA 10/2018 - 10/2008
12	Gefitinib (Iressa)FDA Link 07/2018 - 11/2004
10	Anaplastic Lymphoma KinaseIBA 01/2020 - 01/2013
9	Pemetrexed (MTA)FDA Link 05/2020 - 03/2011
9	alectinibIBA 01/2020 - 02/2015
8	CrizotinibIBA 01/2020 - 01/2013
7	PlatinumIBA 05/2015 - 04/2009
6	Bevacizumab (Avastin)FDA Link 05/2020 - 07/2010
4	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2018
4	Carboplatin (JM8)FDA LinkGeneric 05/2020 - 09/2009
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2009
4	SolventsIBA 10/2017 - 12/2013
4	Gemcitabine FDA Link 12/2013 - 09/2009
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 04/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 01/2015
3	Albumin-Bound Paclitaxel FDA Link 10/2017 - 05/2016
3	Phosphotransferases (Kinase)IBA 02/2015 - 04/2010
3	Pharmaceutical PreparationsIBA 07/2013 - 09/2011
3	Epidermal Growth Factor (EGF)IBA 09/2012 - 04/2010
3	OSI-420IBA 09/2011 - 05/2010
2	amrubicinIBA 03/2020 - 05/2010
2	Formaldehyde (Formol)FDA Link 05/2019 - 02/2013
2	ParaffinIBA 05/2019 - 02/2013
2	AfatinibIBA 01/2019 - 01/2017
2	ceritinibIBA 11/2018 - 09/2018
2	130-nm albumin-bound paclitaxelIBA 10/2017 - 07/2016
2	AlbuminsIBA 10/2017 - 07/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2017 - 09/2012
2	Cisplatin (Platino)FDA LinkGeneric 11/2015 - 04/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 08/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2013 - 04/2011
2	Insulin-Like PeptidesIBA 09/2012 - 10/2011
2	Insulin-Like Growth Factor Binding Protein 3IBA 09/2012 - 10/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012 - 11/2010
2	BRCA1 ProteinIBA 07/2009 - 04/2009
1	B7-H1 AntigenIBA 06/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2022
1	durvalumabIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	navitoclaxIBA 01/2020
1	S63845IBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	LigandsIBA 01/2020
1	Anti-Infective Agents (Microbicides)IBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	saracatinibIBA 01/2019
1	src-Family KinasesIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	osimertinibIBA 06/2018
1	omega-Chloroacetophenone (Mace)IBA 09/2017
1	locked nucleic acidIBA 01/2017
1	Peptide Nucleic AcidsIBA 01/2017
1	Circulating Tumor DNAIBA 01/2017

Therapy/Procedure

29	Drug Therapy (Chemotherapy) 12/2021 - 05/2006
14	Therapeutics 01/2021 - 01/2010
4	Chemoradiotherapy 01/2021 - 03/2016
3	Radiotherapy 01/2022 - 05/2006
3	Drug-Eluting Stents 06/2014 - 11/2008
3	Percutaneous Coronary Intervention 06/2014 - 02/2012
3	Combination Drug Therapy (Combination Chemotherapy) 11/2011 - 07/2009
2	Cranial Irradiation 08/2021 - 12/2016
2	Aftercare (After-Treatment) 01/2020 - 09/2017
2	Immunotherapy 01/2020 - 01/2019
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2014 - 11/2013
2	Maintenance Chemotherapy 01/2013 - 11/2011
2	Renal Dialysis (Hemodialysis) 04/2011 - 05/2010